Rentokil Initial (LON:RTO – Get Free Report)‘s stock had its “outperform” rating reaffirmed by research analysts at Royal Bank of Canada in a research note issued on Wednesday, Digital Look reports. They presently have a GBX 570 ($7.33) price target on the stock. Royal Bank of Canada’s target price would indicate a potential upside of 20.41% from the stock’s previous close.
Several other research firms have also commented on RTO. Jefferies Financial Group reiterated a “buy” rating and issued a GBX 600 ($7.72) price objective on shares of Rentokil Initial in a research note on Thursday, April 18th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a GBX 500 ($6.43) price objective on shares of Rentokil Initial in a research note on Tuesday, July 2nd.
Rentokil Initial Trading Up 1.0 %
Insider Activity
In related news, insider Sally Johnson bought 2,493 shares of Rentokil Initial stock in a transaction dated Wednesday, June 26th. The stock was purchased at an average cost of GBX 462 ($5.94) per share, with a total value of £11,517.66 ($14,815.62). Insiders own 1.10% of the company’s stock.
About Rentokil Initial
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Recommended Stories
- Five stocks we like better than Rentokil Initial
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Invest Like Congress: 2 ETFs to Add to Your Watchlist
- How to Use the MarketBeat Excel Dividend Calculator
- AI Boom or Bubble? Strategies for Success in a Volatile Sector
- What is Insider Trading? What You Can Learn from Insider Trading
- Oilfield Infrastructure Stock Soars Over 50% on Bold Acquisition
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.